What is the BALLETS (no expansion available) study?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

The BALLETS Study: Birmingham and Lambeth Liver Evaluation Testing Strategies

Study Overview

The BALLETS study was a landmark prospective cohort study that evaluated the optimal testing strategies for abnormal liver blood tests in primary care patients without pre-existing or self-evident liver disease. 1

The study enrolled 1,290 adults from primary care settings in Birmingham and Lambeth, UK, who were fully characterized and followed for 2 years. 1 This research fundamentally shaped current guidelines on which liver blood tests should be ordered and how to investigate abnormal results. 1

Key Findings on Liver Test Panel Composition

Optimal Initial Testing Strategy

  • ALT and ALP identified the vast majority of adults with liver disease, making them the cornerstone tests. 1
  • Adding GGT to the panel increased sensitivity marginally but at the cost of decreased specificity and higher false-positive rates, raising the proportion of patients with abnormal results from approximately 15% to 30%. 1
  • Routine addition of AST to the initial panel did not improve detection of specific liver diseases. 1

Important Caveats

The BALLETS analysis did not include adults with NAFLD or alcohol-related liver disease (ARLD), which account for 90% of liver mortality. 1 In these populations, GGT and AST would likely improve sensitivity for detection. 1 This limitation explains why current guidelines still recommend including GGT in the initial panel despite its lower specificity. 1

Prevalence of Specific Liver Diseases

Low Yield of Specific Diagnoses

  • Less than 5% of people with abnormal liver blood tests had a specific disease affecting the liver. 1
  • Only 1.3% had a specific liver disease requiring immediate treatment: 13 patients with viral hepatitis and 4 with genetic hemochromatosis. 1
  • Country of origin (not ethnic group) was the strongest predictor of viral hepatitis. 1

High Prevalence of Fatty Liver

  • Nearly 40% of adults had fatty liver on ultrasound. 1
  • Abnormal ALT concentration was the strongest laboratory predictor of fatty liver on imaging. 1
  • Obesity was more strongly associated with fatty liver than alcohol excess, but one-quarter of adults with fatty liver were neither overweight nor excessive alcohol drinkers. 1

Impact on Clinical Guidelines

Streamlined Testing Approach

The BALLETS data supported a strategy of using a streamlined panel with high sensitivity without generating excessive false positives, which would lead to greater patient anxiety, over-investigation, and increased costs. 1

Current guidelines now recommend initial investigation include: bilirubin, albumin, ALT, ALP, and GGT, together with a full blood count if not performed within the previous 12 months. 1

AST:ALT Ratio for Fibrosis Assessment

While AST is not recommended in the initial panel, the BALLETS study informed the recommendation for subsequent AST testing to calculate the AST:ALT ratio. 1 An AST:ALT ratio >1 indicates advanced fibrosis/cirrhosis, and this ratio remains useful even when both values are within normal reference intervals. 1

Reflex Testing Strategy

The study suggested that reflex testing (automatically performing AST on the same sample when ALT or GGT is abnormal) would be more cost-effective than routine dual testing, though definitive cost-effectiveness data were still awaited at the time of guideline publication. 1

Viral Hepatitis Testing Strategy

A subsequent cost-minimization analysis of the BALLETS cohort examined strategies for detecting chronic viral hepatitis in patients with abnormal liver tests. 2

Testing all patients for viral hepatitis without repeating liver function tests was more efficient than the strategy of repeating LFTs before viral testing. 2 The most efficient approach was testing patients born in countries where viral hepatitis is prevalent, which provided high efficiency with minimal loss of sensitivity. 2

Related Questions

What is the recommended course of action for a patient with mildly elevated ALT and low protein levels?
Can liver function tests (LFTs) be normal in patients with hepatitis?
Are liver function tests (LFTs) necessary for routine admission screening?
What is the initial workup for a patient with elevated Liver Function Tests (LFTs) in a primary care setting?
What lab work is necessary for a patient suspected of having hepatitis?
What are the characteristic ECG (electrocardiogram) findings for premature ventricular beats, hypokalemia (low potassium levels), hyperkalemia (high potassium levels), atrial fibrillation, hypermagnesemia (elevated magnesium levels), hypomagnesemia (low magnesium levels), acute pericarditis, Brugada's syndrome, STEMI (ST-elevation myocardial infarction), hypertrophic obstructive cardiomyopathy, and bundle branch blocks?
What is the best course of action for a patient with a history of asthma, anxiety, and anemia, presenting with heart palpitations, chest pain, and left arm tingling, despite a normal cardiology workup and well-controlled asthma and anxiety?
What is the management of posterior reversible encephalopathy syndrome (PRES)?
What are the recent statistics on the global maternal mortality rate?
Can gastric issues cause diarrhea?
What are the characteristic ECG (electrocardiogram) findings for premature ventricular beats, hypokalemia (low potassium levels), hyperkalemia (high potassium levels), atrial fibrillation, hypermagnesemia (elevated magnesium levels), hypomagnesemia (low magnesium levels), acute pericarditis, Brugada's syndrome, STEMI (ST-elevation myocardial infarction), hypertrophic obstructive cardiomyopathy, and bundle branch blocks?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.